Share this
Lavoro to Become Publicly Traded Through Business Combination With TPB Acquisition Corporation I
September 20, 2022
Chambers USA 2022 Recognizes Cooley Lawyers + Practices
June 2, 2022
Grindr Agrees to Merge With SPAC Tiga Acquisition Corp.
Transaction will support social network’s growth, launch new endeavors and continue its work to advance best interests of global LGBTQ+ community • May 10, 2022
Electric-Vehicle Startups are Experiencing a Gold Rush. Here are the Top 9 Lawyers Helping Them Navigate the Financial Frenzy.
Insider • December 20, 2021
Lulu’s – $92 Million IPO
November 17, 2021
Chambers USA 2021 Recognizes Cooley Lawyers + Practices
May 28, 2021
SPAC Transactions – Considerations for Target-Company CFOs
Cooley and Deloitte • October 2, 2020
EV Maker Canoo to List on Nasdaq Through Hennessy Capital Merger
August 19, 2020
Hyliion to Combine With Tortoise, a Special Purpose Acquisition Company
June 22, 2020
The Recorder Names Cooley Firm of Year for Tech Deals + Emerging Companies
Awards also honor partner Siana Lowrey on Women Leaders in Tech list • November 7, 2019
Startup Firm/Emerging Company Law Firm of the Year
The Recorder • November 6, 2019
Tech Deal Department of the Year
Top 40 Under 40
Daily Journal • August 16, 2019
Gossamer Bio – $317 Million IPO
One of the largest healthcare IPOs of the last 20 years • February 21, 2019
Taiwan Liposome Company Completes US IPO
January 3, 2019
Cooley Elects 19 New Partners for January 1, 2019
November 28, 2018
ASLAN Pharmaceuticals – $42 Million IPO
First Taipei Exchange-listed company to go public in US • June 8, 2018
Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering
September 22, 2017
Cooley Advises on Series of Life Sciences IPOs
Zymeworks, Verona, UroGen and Biohaven IPOs highlight core strengths across the sector • May 30, 2017
Audentes – $86 Million Shelf-Takedown Offering
April 27, 2017
Alteryx – $145 Million IPO
April 12, 2017
Vital Therapies – $40 Million Follow-on Offering
March 29, 2017
Anthera – $15 Million Shelf-Takedown Offering
March 22, 2017
Dermira – $194 Million Shelf-Takedown
March 10, 2017
Global Blood Therapeutics – $144 Million Shelf‑Takedown
March 8, 2017
Sierra Oncology – $29.5 Million Shelf-Takedown
February 23, 2017
Mirati – $69 Million Shelf-Takedown
January 12, 2017
NantHealth – $107 Million Notes Offering
January 11, 2017
Invitae – $51 Million Follow-On
November 30, 2016
HealthEquity – $90 Million Follow-On
November 4, 2016
BioMarin – $720 Million Follow-On
September 19, 2016
Xenon Pharmaceuticals – $34.5 Million Follow-On
September 16, 2016
Sophiris Bio – $30 Million Follow-On
September 13, 2016
Gemphire Therapeutics – $30 Million IPO
August 22, 2016
Dermira – $145 Million Follow-On Offering
June 23, 2016
NantHealth IPO – $97 Million
June 13, 2016
NantKwest – $238 Million IPO
August 14, 2015
ProNAi – $158 Million IPO
August 7, 2015
MINDBODY Completes $100 Million IPO
June 26, 2015
FireEye Completes 144A Private Placement of $920 Million Convertible Senior Notes
June 10, 2015
Apigee Completes Its Initial Public Offering
May 11, 2015
InsideSales.com Tops $200 Million in Capital with Latest $60 Million Round
March 25, 2015
Invitae Completes $117 Million Initial Public Offering
February 25, 2015
TRACON Pharmaceuticals Completes Initial Public Offering
February 13, 2015
Ascendis Pharma Closes $124 Million Initial Public Offering
Xenon Pharmaceuticals Completes its Initial Public Offering
November 21, 2014
Dermira Prices its Initial Public Offering
October 27, 2014
Cooley Advises Underwriters on Otonomy IPO
August 19, 2014
Cooley Advises Underwriters on HealthEquity's $146.5 Million IPO
August 11, 2014
Cooley Advises Underwriters on Immune Design IPO
Cooley Advises Underwriters on Minerva Neurosciences IPO
July 11, 2014
Cooley Advises Kite Pharma on $146 Million Initial Public Offering
July 1, 2014
Cooley Advises Underwriters on Vital Therapies Initial Public Offering
April 23, 2014
Cooley Advises Underwriters on Amedica IPO
March 4, 2014
Cooley Advises Celladon on its Initial Public Offering
February 11, 2014
Cooley Advises Xencor on its Initial Public Offering
December 10, 2013
Cooley, Latham Line Up Celladon IPO (The Recorder)
November 13, 2013
Cooley Advises Underwriters on Five Prime Therapeutics IPO
September 23, 2013
Cooley Advises Underwriters on Receptos, Inc. Initial Public Offering
May 20, 2013